NE

Nephrogen

YC S20 ↗Techstars '25

New York City, US · Founded 2022 · 5 employees · 3 known investors

nephrogenbiotech.com ↗

Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.

Founders & leadership· Y Combinator alumni (S20)

DM

Demetri MaximFounder and CEO

VB

Vivek BhallaChief Medical Officer

Investors · 3

TE

TechstarsBoulder · $220K

Y

Y CombinatorSan Francisco · $500K

ZA

ZAKA VCSan Francisco